LIQUICHEK CARDIAC MARKERS CONTROL (CAT. NO. 685,686,687,688)

K961828 · Bio-Rad · JJT · Jun 11, 1996 · Clinical Chemistry

Device Facts

Record IDK961828
Device NameLIQUICHEK CARDIAC MARKERS CONTROL (CAT. NO. 685,686,687,688)
ApplicantBio-Rad
Product CodeJJT · Clinical Chemistry
Decision DateJun 11, 1996
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 862.1660
Device ClassClass 1

Intended Use

Liquichek Cardiac Markers Control is intended for use as an assayed quality control serum to monitor the precision of an individual laboratory’s specific cardiac marker procedures.

Device Story

Liquichek Cardiac Markers Control; liquid quality control serum; human serum base with human/non-human additives. Used in clinical laboratories by laboratory personnel to monitor precision of cardiac marker assays. Product serves as reference material to verify analytical performance of diagnostic testing procedures. Provides stability for 20 days at 2-8°C (10 days for Troponin T).

Clinical Evidence

Bench testing only. No clinical data provided. Substantial equivalence established through comparison of physical form, matrix, storage conditions, and stability performance.

Technological Characteristics

Liquid human serum matrix; additives of human and non-human origin. Storage: -10 to -20°C. Open vial stability: 20 days at 2-8°C (10 days for Troponin T).

Indications for Use

Indicated for use as an assayed quality control serum in clinical laboratories to monitor the precision of cardiac marker testing procedures. No specific patient population, age, or gender restrictions apply as this is an in vitro diagnostic control material.

Regulatory Classification

Identification

A quality control material (assayed and unassayed) for clinical chemistry is a device intended for medical purposes for use in a test system to estimate test precision and to detect systematic analytical deviations that may arise from reagent or analytical instrument variation. A quality control material (assayed and unassayed) may be used for proficiency testing in interlaboratory surveys. This generic type of device includes controls (assayed and unassayed) for blood gases, electrolytes, enzymes, multianalytes (all kinds), single (specified) analytes, or urinalysis controls.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0} BIO-RAD Bio-Rad Laboratories ECS Division 3726 E. Miraloma Avenue Anaheim, CA 92806 Telephone (714) 630-6400 Toll Free (800) 654-6737 K961828 JUN 11 1996 ## 510(k) Summary **Submitter** Bio-Rad Laboratories, ECS Division 3726 E. Miraloma Avenue Anaheim, CA 92806 (714)630-6400 Fax (714)666-1383 **Contact Person** Elizabeth Platt **Date of Summary Preparation** May 8, 1996 **Device (Trade & Common Name)** Liquichek Cardiac Markers Control **Classification Name** CFR 862.1660: Quality Control Material (Assayed and Unassayed) **Devices to Which Substantial Equivalence is Claimed** Liquichek CK/LD Isoenzyme Control Bio-Rad Laboratories, Anaheim, CA K903430 **Statement of Intended Use** Liquichek Cardiac Markers Control is intended for use as an assayed quality control serum to monitor the precision of an individual laboratory’s specific cardiac marker procedures. 35 {1} BIO-RAD Bio-Rad Laboratories ECS Division 3726 E. Miraloma Avenue Anaheim, CA 92806 Telephone (714) 630-6400 Toll Free (800) 854-6737 ## Description of the Device Liquichek Cardiac Markers Control is prepared from human serum with added constituents of human and non-human origin. The control is provided in liquid form for convenience. ## Statement of How Technological Characteristics Compare to Substantial Equivalence Device A table is provided below comparing the similarities between the Bio-Rad Liquichek Cardiac Markers Control and the devices to which substantial equivalence is claimed. | | Bio-Rad Liquichek Cardiac Markers Control | Bio-Rad CK/LD Isoenzyme Control | | --- | --- | --- | | Intended Use | To monitor the precision of a laboratories specific cardiac markers procedures. | To monitor the precision of a laboratories CK (Creatine Kinase), LD (Lactate Dehydrogenase) and serum protein testing procedures. | | Form | Liquid | Liquid | | Matrix | Human Serum | Human Serum | | Storage | -10 to -20°C | -10 to -20°C | | Open Vial Claim | 20 Days at 2-8°C for all analytes; except Troponin T which is stable for 10 Days at 2-8°C | 10 Days at 2-8°C |
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...